Controlling Childhood Myopia Progression: A Systematic Review of Interventions
Journal of Ophthalmic and Optometric Sciences · 05.04.2025
DOI: 10.22037/joos.v9i2.50684 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Ophthalmic and Optometric Sciences, erschienen am 05.04.2025. Verfasst von Alireza Sadeghi und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
To synthesize evidence on risk factors and interventions for slowing myopia progression in children and adolescents.
Methods
PubMed, Scopus, Embase, and Web of Science were searched through December 2023. Eligible studies included randomized and observational designs evaluating environmental factors, specialized spectacle lenses (defocus incorporated multiple segments [DIMS], highly aspherical lens [HAL], slightly aspherical lens [SAL]), multifocal or dual-focus soft contact lenses, orthokeratology, low-dose atropine, and repeated low-level red-light therapy. Two reviewers independently screened and extracted data. Risk of bias was assessed with Cochrane RoB 2 for randomized trials and the Newcastle–Ottawa Scale for observational studies. Outcomes were annual change in spherical equivalent refraction (diopters/year) and axial length (millimeters/year).
Results
Increased outdoor time was consistently associated with reduced incidence and slower progression. Specialized spectacle lenses (DIMS, HAL, SAL) and dual-focus/multifocal soft contact lenses slowed refractive change and axial elongation compared with single-vision controls. Orthokeratology effectively reduced axial elongation in appropriately selected eyes. Low-dose atropine produced dose-dependent benefits, with 0.05% generally more effective than 0.01%; rebound varied with dose, treatment duration, and tapering. Emerging evidence for red-light therapy suggested short-term efficacy, but long-term safety and rebound remain uncertain. Combination strategies, such as atropine plus optical interventions, showed additive effects, though data are limited.
Conclusions
Outdoor exposure, low-dose atropine (≈0.05%), DIMS/HAL/SAL spectacle lenses, multifocal or dual-focus soft contact lenses, and orthokeratology show the strongest evidence for slowing childhood myopia. Combination therapy may enhance outcomes, while red-light therapy remains promising but investigational, with long-term safety and rebound still uncertain.
Schlagwörter
Zitieren
APA
Sadeghi, A., Moravej, R., Valipour, A., & Khabazkhoob, M. (2025). Controlling Childhood Myopia Progression: A Systematic Review of Interventions. Journal of Ophthalmic and Optometric Sciences. https://doi.org/10.22037/joos.v9i2.50684
Vancouver
Sadeghi A, Moravej R, Valipour A, Khabazkhoob M. Controlling Childhood Myopia Progression: A Systematic Review of Interventions. Journal of Ophthalmic and Optometric Sciences. 2025. doi:10.22037/joos.v9i2.50684
BibTeX
@article{Sadeghi2025,
author = {Sadeghi, Alireza and Moravej, Raheleh and Valipour, Anahita and Khabazkhoob, Mehdi},
title = {Controlling Childhood Myopia Progression: A Systematic Review of Interventions},
journal = {Journal of Ophthalmic and Optometric Sciences},
year = {2025},
doi = {10.22037/joos.v9i2.50684}
}
EUVIMED